Nexgel (NXGL) Interest & Investment Income (2023 - 2025)

Nexgel (NXGL) reported Interest & Investment Income of $10000.0 for Q3 2025, up 150.0% on a YoY basis from $4000.0 in Q3 2024, and up 147.62% quarter-over-quarter from -$21000.0 in Q2 2025.

Nexgel (NXGL) Interest & Investment Income (2023 - 2025) Analysis & Trends

Nexgel has reported Interest & Investment Income for 3 years, with the latest figure at $10000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 9.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -136.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 12.29 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 5.10 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -62.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 3.91 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -66.00 Mn
10 Nexgel 4.18 Mn 2.81 Mn 819,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2025 10,000.00
Jun 30, 2025 -21,000.00
Mar 31, 2025 -21,000.00
Sep 30, 2024 -20,000.00
Jun 30, 2024 -29,000.00
Mar 31, 2024 -15,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 2,000.00